X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse SUVEN LIFE with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SUVEN LIFE   ADCOCK INGRAM
EQUITY SHARE DATA
    SUVEN LIFE
Mar-16
ADCOCK INGRAM
Jun-14
SUVEN LIFE/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs339399-   
Low Rs144288-   
Sales per share (Unadj.) Rs39.2118.8-  
Earnings per share (Unadj.) Rs7.5-29.9-  
Cash flow per share (Unadj.) Rs8.8-24.8-  
Dividends per share (Unadj.) Rs2.000-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs49.093.3-  
Shares outstanding (eoy) m127.28168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.22.9 212.6%   
Avg P/E ratio x32.4-11.5 -281.8%  
P/CF ratio (eoy) x27.5-13.9 -198.6%  
Price / Book Value ratio x4.93.7 133.7%  
Dividend payout %26.80-   
Avg Mkt Cap Rs m30,73258,031 53.0%   
No. of employees `0001.04.3 22.2%   
Total wages/salary Rs m4163,642 11.4%   
Avg. sales/employee Rs Th5,236.14,671.9 112.1%   
Avg. wages/employee Rs Th436.5848.4 51.4%   
Avg. net profit/employee Rs Th995.5-1,177.2 -84.6%   
INCOME DATA
Net Sales Rs m4,99520,056 24.9%  
Other income Rs m194140 137.8%   
Total revenues Rs m5,18920,197 25.7%   
Gross profit Rs m1,233-3,476 -35.5%  
Depreciation Rs m167866 19.3%   
Interest Rs m54543 10.0%   
Profit before tax Rs m1,205-4,744 -25.4%   
Minority Interest Rs m0-13 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m255296 86.0%   
Profit after tax Rs m950-5,054 -18.8%  
Gross profit margin %24.7-17.3 -142.4%  
Effective tax rate %21.2-6.2 -338.8%   
Net profit margin %19.0-25.2 -75.5%  
BALANCE SHEET DATA
Current assets Rs m4,98614,690 33.9%   
Current liabilities Rs m1,0428,265 12.6%   
Net working cap to sales %79.032.0 246.5%  
Current ratio x4.81.8 269.2%  
Inventory Days Days61111 55.0%  
Debtors Days Days39124 31.6%  
Net fixed assets Rs m3,1268,563 36.5%   
Share capital Rs m12793 136.7%   
"Free" reserves Rs m3,7170-   
Net worth Rs m6,23615,742 39.6%   
Long term debt Rs m4325,532 7.8%   
Total assets Rs m8,07929,738 27.2%  
Interest coverage x23.2-7.7 -300.4%   
Debt to equity ratio x0.10.4 19.7%  
Sales to assets ratio x0.60.7 91.7%   
Return on assets %12.4-15.2 -81.9%  
Return on equity %15.2-32.1 -47.4%  
Return on capital %18.9-19.8 -95.3%  
Exports to sales %87.50-   
Imports to sales %12.20-   
Net fx Rs m3,7240-   
CASH FLOW
From Operations Rs m9221,712 53.9%  
From Investments Rs m-619-526 117.8%  
From Financial Activity Rs m-6985,021 -13.9%  
Net Cashflow Rs m-3966,207 -6.4%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5.51 Rs / ZAR

Compare SUVEN LIFE With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare SUVEN LIFE With: CADILA HEALTHCARE  WYETH LTD  SHASUN PHARMA  ALEMBIC LTD  ELDER PHARMA  



Today's Market

Sensex Finishes Marginally Lower; Capital Goods & Realty Stocks Fall(Closing)

Indian share markets witnessed selling pressure in the final hour of trade to finish just below the dotted line. At the closing bell, the BSE Sensex closed lower by 71 points.

Related Views On News

Suven Lifesciences: Profits Decline due to Higher tax outgo in the quarter (Quarterly Results Update - Detailed)

Sep 22, 2017

Muted growth in CRAMS segment continues to impact topline.

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

More Views on News

Most Popular

Follow India's Super Investors to Make Big Money in the Market Crash(The 5 Minute Wrapup)

Feb 8, 2018

Has the sell-off in the markets left India's super investors unduly worried?

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

Rising Dominance of Mutual Funds(Chart Of The Day)

Feb 8, 2018

Domestic money flow into Indian equities surpassed foreign fund flows in the recent years. But will it continue in volatile market?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SHARE PRICE


Feb 20, 2018 (Close)

TRACK SUVEN LIFE

  • Track your investment in SUVEN LIFE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUVEN LIFE - ALEMBIC PHARMA COMPARISON

COMPARE SUVEN LIFE WITH

MARKET STATS